Evaluation of novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples
Detection Principle
ImmunoAssay-Antigen
Target
Nucleocapsid protein
Testing Method Category
Testing Method
kit
Testing Method - Additional Info
RDT rapid antigen detection kit: fluorescence immunochromatographic SARS-CoV-2 antigen test (Bioeasy Biotechnology Co., Shenzhen, China)
Reported Performance
Sensitivity: 93.9%; specificity: 100%
Sample Size
127 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements